## Note
nid: 1579659417265
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Mepolizumab, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Reslizumab, #AK_Step1_v11::#FirstAid::16_Respiratory::05_Pharm::07_Asthma_Drugs, #AK_Step1_v11::#FirstAid::16_Respiratory::05_Pharm::07_Asthma_Drugs::Anti-IL5_Monoclonal_Therapy, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Physeo::09_Pharm::08_Respiratory::08_Anti-IL-5_Monoclonal_Therapy, #AK_Step1_v11::$AnKingAdds::FA2020::Respiratory, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step1_v11::^Systems::Respiratory::AKadds
markdown: false

### Text
<b>Reslizumab</b> and <b>Mepolizumab</b> are <b>monoclonal
antibodies</b> against {{c1::IL-5}}used for maintenance therapy for
<u>asthma</u>

### Extra
<div><img src="paste-5ada8cde48ce2d2bbe27013ab24fe9173588a53c.jpg"
class="resizer"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

